问答文章1 问答文章501 问答文章1001 问答文章1501 问答文章2001 问答文章2501 问答文章3001 问答文章3501 问答文章4001 问答文章4501 问答文章5001 问答文章5501 问答文章6001 问答文章6501 问答文章7001 问答文章7501 问答文章8001 问答文章8501 问答文章9001 问答文章9501

孩子在学校打的疫苗,姐姐的都可以在穗康码上查得到,妹妹的查不到,怎么办?

发布网友 发布时间:2022-05-01 16:54

我来回答

5个回答

热心网友 时间:2023-10-22 23:50

接种疫苗,不是扎一下,哭两声的小事,更不要被堂而皇之的概念绑架。特别是对于孩子而言,作为家长应该负起守护责任,哪怕需要承受巨大的压力。爱孩子,就该考虑长远,认真分析该疫苗的效用与风险。一个最简单的事实是,疫情发展至今,全美只有四百余位孩子的死亡与新冠有关,医生们仔细研究每个案例,发现这些孩子自身都带有严重疾病,如白血病等。换句话说,至今在美国,没有一个健康的孩子单纯因为新冠而死亡,所以健康孩子的新冠死亡风险几乎为0。新冠疫苗呢?我刚留意到,国内已有一位谭博士做了相关解读:一周前同济大学医学院学者在《Cell Discovery》发表一篇文章,从机体免疫细胞角度分析接种者的病理生理学改变,研究新冠疫苗对接种者带来的免疫干扰。为避免我的解读断章取义,请读者认真阅读全文,其链接如下:虽然研究的疫苗种类不同,这个研究基本呼应了美国Ryan Cole医生等人的观察,即接种新冠疫苗(无论灭活或者mRNA)后,疫苗接种者的生理病理状态,与新冠感染类似。虽然接种疫苗后可以诱导出现某些抗体,但同时导致一系列复杂的免疫机能改变,包括CD4+,CD8+等T细胞表达水平的下降,I类干扰素应答能力受到影响。这意味着疫苗接种者在短期内反而处于某种免疫抑制状态。需要指出,这类受损的免疫机制,不仅用于防护各种病毒感染,也是机体抑制肿瘤细胞的关键,因此,这个细胞免疫学观察,可以解释疫苗接种后导致的带状疱疹(病毒感染),肿瘤突然增大等现象。研究者无法确定,他们所观察到的免疫问题,究竟是仅限于新冠疫苗,还是适用于其他普遍的疫苗。研究者认为,新冠疫苗接种应该对不适应人群进行更为谨慎地筛选,切切不可滥接。同时,应该考虑该疫苗对特定医疗状况以及人类健康的长期负面影响。AbstractLarge-scale COVID-19 vaccinations are currently underway in many countries in response to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine. Similar changes had also been reported in COVID-19 patients, suggesting that vaccination mimicked an infection. Single-cell mRNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) before and 28 days after the first inoculation also revealed consistent alterations in gene expression of many different immune cell types. Rection of CD8+ T cells and increase in classic monocyte contents were exemplary. Moreover, scRNA-seq revealed increased NF-κB signaling and reced type I interferon responses, which were confirmed by biological assays and also had been reported to occur after SARS-CoV-2 infection with aggravating symptoms. Altogether, our study recommends additional caution when vaccinating people with pre-existing clinical conditions, including diabetes, electrolyte imbalances, renal dysfunction, and coagulation disorders.Subject terms: Immunology, TranscriptomicsIntroctionThe COVID-19 pandemic has profoundly affected humanity. The development of COVID-19 vaccines in various forms has been underway in an unprecedented and accelerated manner. Despite some uncertainties regarding potential consequences, large-scale vaccinations are taking place in many countries. There have been different COVID-19 vaccines developed, including inactivated viral particles, mRNA vaccines, adenoviral-based vaccines, and etc.1–5. Historically, vaccine research has been focused on whether or not vaccination could generate neutralizing antibodies to protect against viral infections, whereas short-term and long-term influences of the various newly developed vaccines to human pathophysiology and other perspectives of the human immune system have not been fully investigated.With the development of large-scale single-cell mRNA sequencing (scRNA-seq) technology, systematic investigation of people’s immune system function with precision became possible, primarily through scRNA-seq of peripheral blood mononuclear cells (PBMCs). During the COVID-19 pandemic, a large body of studies using scRNA-seq of PBMCs had revealed detailed changes in gene expression in different immune cell subtypes including different types of T and B cells, NK cells, monocytes, dendritic cells, etc. ring and after infection, results from which indicated greatly reced CD4+ and CD8+ T-cell numbers and T-cell exhaustion upon SARS-CoV-2 infection. Reced peripheral mucosal-associated invariable T (MAIT) cell numbers and their migration in and out of the lung had also been observed. Highly activated inflammatory immune responses, including Interferon-gamma (IFN-γ), interleukin-6 (IL-6), and NF-κB responses, had been reported in COVID-19 patients6–12. Many studies had revealed immune state differences between people with severe versus mild symptoms, in that strong type I interferon (IFN-α/β) responses were beneficial after COVID-19 infection and attenuated IFN-α/β responses were associated with the development of severe symptoms13. In contrast, stronger NF-κB inflammatory responses were associated with more severe symptoms14. In addition, increased γδ-T cell and reced neutrophil contents were reported to be associated with milder symptoms15.Upon SARS-CoV-2 infections, many people developed various degrees of respiratory syndromes, and some with gastrointestinal conditions. It had been reported that blood coagulation disorders, vasculature issues, electrolytes imbalances, renal disorders, metabolic disorders, etc. were major clinical complications with COVID-1916,17. The manner in which vaccination would mimic an infection has not been fully evaluated. In this study, we enrolled healthy volunteers who were to be vaccinated with an inactivated SARS-CoV-2 vaccine (Vero Cell)3, to participate in antibody and neutralizing antibody testings, as well as detailed clinical laboratory measurements before and at different times after vaccination (two-dose regimens with slightly different scheles were applied). To our surprise, we observed quite consistent pathophysiological changes regarding electrolyte contents, coagulation profiles, renal function as well as cholesterol and glucose metabolic-related features, as if these people had experienced an infection with SARS-CoV-2. In addition, PBMCs scRNA-seq results also indicated consistent rections in CD8+ T cells and increases in monocyte contents, as well as enhanced NF-κB inflammatory signaling, which also mimicked responses after infection. Surprisingly, type I interferon responses, which had been linked to reced damages after SARS-CoV-2 infection and milder symptoms, appeared to be reced after vaccination, at least by 28 days post the 1st inoculation. This might suggest that in the short-term (1 month) after vaccination, a person’s immune system is in a non-privileged state, and may require more protection.

热心网友 时间:2023-10-22 23:50

这个东西在哪个地图打的疫苗拿身份证去的 ,该都是有一个单子的 ,你问一下学校的老师 ,让老师帮着问一下 ,这是让老师告诉你,打疫苗的单位自己去查 ,情况是网上查询确实是滞后的 ,这网络更新以后,你的数据可能上传的比较晚,这个不要着急

热心网友 时间:2023-10-22 23:51

可能是学校做记录的时候给落下了,可以去学校查查看看,如果接种了,学校是有记录的,能不能让学校给补录一下。

热心网友 时间:2023-10-22 23:51

是不是刚打完的事儿啊,过两天了可能就能查到了,查不到的话去学校核实一下,应该有记录的

热心网友 时间:2023-10-22 23:52

应该是妹妹没有录入数据库,联系防疫站,把妹妹的信息录进去。

热心网友 时间:2023-10-22 23:50

接种疫苗,不是扎一下,哭两声的小事,更不要被堂而皇之的概念绑架。特别是对于孩子而言,作为家长应该负起守护责任,哪怕需要承受巨大的压力。爱孩子,就该考虑长远,认真分析该疫苗的效用与风险。一个最简单的事实是,疫情发展至今,全美只有四百余位孩子的死亡与新冠有关,医生们仔细研究每个案例,发现这些孩子自身都带有严重疾病,如白血病等。换句话说,至今在美国,没有一个健康的孩子单纯因为新冠而死亡,所以健康孩子的新冠死亡风险几乎为0。新冠疫苗呢?我刚留意到,国内已有一位谭博士做了相关解读:一周前同济大学医学院学者在《Cell Discovery》发表一篇文章,从机体免疫细胞角度分析接种者的病理生理学改变,研究新冠疫苗对接种者带来的免疫干扰。为避免我的解读断章取义,请读者认真阅读全文,其链接如下:虽然研究的疫苗种类不同,这个研究基本呼应了美国Ryan Cole医生等人的观察,即接种新冠疫苗(无论灭活或者mRNA)后,疫苗接种者的生理病理状态,与新冠感染类似。虽然接种疫苗后可以诱导出现某些抗体,但同时导致一系列复杂的免疫机能改变,包括CD4+,CD8+等T细胞表达水平的下降,I类干扰素应答能力受到影响。这意味着疫苗接种者在短期内反而处于某种免疫抑制状态。需要指出,这类受损的免疫机制,不仅用于防护各种病毒感染,也是机体抑制肿瘤细胞的关键,因此,这个细胞免疫学观察,可以解释疫苗接种后导致的带状疱疹(病毒感染),肿瘤突然增大等现象。研究者无法确定,他们所观察到的免疫问题,究竟是仅限于新冠疫苗,还是适用于其他普遍的疫苗。研究者认为,新冠疫苗接种应该对不适应人群进行更为谨慎地筛选,切切不可滥接。同时,应该考虑该疫苗对特定医疗状况以及人类健康的长期负面影响。AbstractLarge-scale COVID-19 vaccinations are currently underway in many countries in response to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine. Similar changes had also been reported in COVID-19 patients, suggesting that vaccination mimicked an infection. Single-cell mRNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) before and 28 days after the first inoculation also revealed consistent alterations in gene expression of many different immune cell types. Rection of CD8+ T cells and increase in classic monocyte contents were exemplary. Moreover, scRNA-seq revealed increased NF-κB signaling and reced type I interferon responses, which were confirmed by biological assays and also had been reported to occur after SARS-CoV-2 infection with aggravating symptoms. Altogether, our study recommends additional caution when vaccinating people with pre-existing clinical conditions, including diabetes, electrolyte imbalances, renal dysfunction, and coagulation disorders.Subject terms: Immunology, TranscriptomicsIntroctionThe COVID-19 pandemic has profoundly affected humanity. The development of COVID-19 vaccines in various forms has been underway in an unprecedented and accelerated manner. Despite some uncertainties regarding potential consequences, large-scale vaccinations are taking place in many countries. There have been different COVID-19 vaccines developed, including inactivated viral particles, mRNA vaccines, adenoviral-based vaccines, and etc.1–5. Historically, vaccine research has been focused on whether or not vaccination could generate neutralizing antibodies to protect against viral infections, whereas short-term and long-term influences of the various newly developed vaccines to human pathophysiology and other perspectives of the human immune system have not been fully investigated.With the development of large-scale single-cell mRNA sequencing (scRNA-seq) technology, systematic investigation of people’s immune system function with precision became possible, primarily through scRNA-seq of peripheral blood mononuclear cells (PBMCs). During the COVID-19 pandemic, a large body of studies using scRNA-seq of PBMCs had revealed detailed changes in gene expression in different immune cell subtypes including different types of T and B cells, NK cells, monocytes, dendritic cells, etc. ring and after infection, results from which indicated greatly reced CD4+ and CD8+ T-cell numbers and T-cell exhaustion upon SARS-CoV-2 infection. Reced peripheral mucosal-associated invariable T (MAIT) cell numbers and their migration in and out of the lung had also been observed. Highly activated inflammatory immune responses, including Interferon-gamma (IFN-γ), interleukin-6 (IL-6), and NF-κB responses, had been reported in COVID-19 patients6–12. Many studies had revealed immune state differences between people with severe versus mild symptoms, in that strong type I interferon (IFN-α/β) responses were beneficial after COVID-19 infection and attenuated IFN-α/β responses were associated with the development of severe symptoms13. In contrast, stronger NF-κB inflammatory responses were associated with more severe symptoms14. In addition, increased γδ-T cell and reced neutrophil contents were reported to be associated with milder symptoms15.Upon SARS-CoV-2 infections, many people developed various degrees of respiratory syndromes, and some with gastrointestinal conditions. It had been reported that blood coagulation disorders, vasculature issues, electrolytes imbalances, renal disorders, metabolic disorders, etc. were major clinical complications with COVID-1916,17. The manner in which vaccination would mimic an infection has not been fully evaluated. In this study, we enrolled healthy volunteers who were to be vaccinated with an inactivated SARS-CoV-2 vaccine (Vero Cell)3, to participate in antibody and neutralizing antibody testings, as well as detailed clinical laboratory measurements before and at different times after vaccination (two-dose regimens with slightly different scheles were applied). To our surprise, we observed quite consistent pathophysiological changes regarding electrolyte contents, coagulation profiles, renal function as well as cholesterol and glucose metabolic-related features, as if these people had experienced an infection with SARS-CoV-2. In addition, PBMCs scRNA-seq results also indicated consistent rections in CD8+ T cells and increases in monocyte contents, as well as enhanced NF-κB inflammatory signaling, which also mimicked responses after infection. Surprisingly, type I interferon responses, which had been linked to reced damages after SARS-CoV-2 infection and milder symptoms, appeared to be reced after vaccination, at least by 28 days post the 1st inoculation. This might suggest that in the short-term (1 month) after vaccination, a person’s immune system is in a non-privileged state, and may require more protection.

热心网友 时间:2023-10-22 23:50

这个东西在哪个地图打的疫苗拿身份证去的 ,该都是有一个单子的 ,你问一下学校的老师 ,让老师帮着问一下 ,这是让老师告诉你,打疫苗的单位自己去查 ,情况是网上查询确实是滞后的 ,这网络更新以后,你的数据可能上传的比较晚,这个不要着急

热心网友 时间:2023-10-22 23:51

可能是学校做记录的时候给落下了,可以去学校查查看看,如果接种了,学校是有记录的,能不能让学校给补录一下。

热心网友 时间:2023-10-22 23:50

接种疫苗,不是扎一下,哭两声的小事,更不要被堂而皇之的概念绑架。特别是对于孩子而言,作为家长应该负起守护责任,哪怕需要承受巨大的压力。爱孩子,就该考虑长远,认真分析该疫苗的效用与风险。一个最简单的事实是,疫情发展至今,全美只有四百余位孩子的死亡与新冠有关,医生们仔细研究每个案例,发现这些孩子自身都带有严重疾病,如白血病等。换句话说,至今在美国,没有一个健康的孩子单纯因为新冠而死亡,所以健康孩子的新冠死亡风险几乎为0。新冠疫苗呢?我刚留意到,国内已有一位谭博士做了相关解读:一周前同济大学医学院学者在《Cell Discovery》发表一篇文章,从机体免疫细胞角度分析接种者的病理生理学改变,研究新冠疫苗对接种者带来的免疫干扰。为避免我的解读断章取义,请读者认真阅读全文,其链接如下:虽然研究的疫苗种类不同,这个研究基本呼应了美国Ryan Cole医生等人的观察,即接种新冠疫苗(无论灭活或者mRNA)后,疫苗接种者的生理病理状态,与新冠感染类似。虽然接种疫苗后可以诱导出现某些抗体,但同时导致一系列复杂的免疫机能改变,包括CD4+,CD8+等T细胞表达水平的下降,I类干扰素应答能力受到影响。这意味着疫苗接种者在短期内反而处于某种免疫抑制状态。需要指出,这类受损的免疫机制,不仅用于防护各种病毒感染,也是机体抑制肿瘤细胞的关键,因此,这个细胞免疫学观察,可以解释疫苗接种后导致的带状疱疹(病毒感染),肿瘤突然增大等现象。研究者无法确定,他们所观察到的免疫问题,究竟是仅限于新冠疫苗,还是适用于其他普遍的疫苗。研究者认为,新冠疫苗接种应该对不适应人群进行更为谨慎地筛选,切切不可滥接。同时,应该考虑该疫苗对特定医疗状况以及人类健康的长期负面影响。AbstractLarge-scale COVID-19 vaccinations are currently underway in many countries in response to the COVID-19 pandemic. Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine. Similar changes had also been reported in COVID-19 patients, suggesting that vaccination mimicked an infection. Single-cell mRNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) before and 28 days after the first inoculation also revealed consistent alterations in gene expression of many different immune cell types. Rection of CD8+ T cells and increase in classic monocyte contents were exemplary. Moreover, scRNA-seq revealed increased NF-κB signaling and reced type I interferon responses, which were confirmed by biological assays and also had been reported to occur after SARS-CoV-2 infection with aggravating symptoms. Altogether, our study recommends additional caution when vaccinating people with pre-existing clinical conditions, including diabetes, electrolyte imbalances, renal dysfunction, and coagulation disorders.Subject terms: Immunology, TranscriptomicsIntroctionThe COVID-19 pandemic has profoundly affected humanity. The development of COVID-19 vaccines in various forms has been underway in an unprecedented and accelerated manner. Despite some uncertainties regarding potential consequences, large-scale vaccinations are taking place in many countries. There have been different COVID-19 vaccines developed, including inactivated viral particles, mRNA vaccines, adenoviral-based vaccines, and etc.1–5. Historically, vaccine research has been focused on whether or not vaccination could generate neutralizing antibodies to protect against viral infections, whereas short-term and long-term influences of the various newly developed vaccines to human pathophysiology and other perspectives of the human immune system have not been fully investigated.With the development of large-scale single-cell mRNA sequencing (scRNA-seq) technology, systematic investigation of people’s immune system function with precision became possible, primarily through scRNA-seq of peripheral blood mononuclear cells (PBMCs). During the COVID-19 pandemic, a large body of studies using scRNA-seq of PBMCs had revealed detailed changes in gene expression in different immune cell subtypes including different types of T and B cells, NK cells, monocytes, dendritic cells, etc. ring and after infection, results from which indicated greatly reced CD4+ and CD8+ T-cell numbers and T-cell exhaustion upon SARS-CoV-2 infection. Reced peripheral mucosal-associated invariable T (MAIT) cell numbers and their migration in and out of the lung had also been observed. Highly activated inflammatory immune responses, including Interferon-gamma (IFN-γ), interleukin-6 (IL-6), and NF-κB responses, had been reported in COVID-19 patients6–12. Many studies had revealed immune state differences between people with severe versus mild symptoms, in that strong type I interferon (IFN-α/β) responses were beneficial after COVID-19 infection and attenuated IFN-α/β responses were associated with the development of severe symptoms13. In contrast, stronger NF-κB inflammatory responses were associated with more severe symptoms14. In addition, increased γδ-T cell and reced neutrophil contents were reported to be associated with milder symptoms15.Upon SARS-CoV-2 infections, many people developed various degrees of respiratory syndromes, and some with gastrointestinal conditions. It had been reported that blood coagulation disorders, vasculature issues, electrolytes imbalances, renal disorders, metabolic disorders, etc. were major clinical complications with COVID-1916,17. The manner in which vaccination would mimic an infection has not been fully evaluated. In this study, we enrolled healthy volunteers who were to be vaccinated with an inactivated SARS-CoV-2 vaccine (Vero Cell)3, to participate in antibody and neutralizing antibody testings, as well as detailed clinical laboratory measurements before and at different times after vaccination (two-dose regimens with slightly different scheles were applied). To our surprise, we observed quite consistent pathophysiological changes regarding electrolyte contents, coagulation profiles, renal function as well as cholesterol and glucose metabolic-related features, as if these people had experienced an infection with SARS-CoV-2. In addition, PBMCs scRNA-seq results also indicated consistent rections in CD8+ T cells and increases in monocyte contents, as well as enhanced NF-κB inflammatory signaling, which also mimicked responses after infection. Surprisingly, type I interferon responses, which had been linked to reced damages after SARS-CoV-2 infection and milder symptoms, appeared to be reced after vaccination, at least by 28 days post the 1st inoculation. This might suggest that in the short-term (1 month) after vaccination, a person’s immune system is in a non-privileged state, and may require more protection.

热心网友 时间:2023-10-22 23:51

是不是刚打完的事儿啊,过两天了可能就能查到了,查不到的话去学校核实一下,应该有记录的

热心网友 时间:2023-10-22 23:50

这个东西在哪个地图打的疫苗拿身份证去的 ,该都是有一个单子的 ,你问一下学校的老师 ,让老师帮着问一下 ,这是让老师告诉你,打疫苗的单位自己去查 ,情况是网上查询确实是滞后的 ,这网络更新以后,你的数据可能上传的比较晚,这个不要着急

热心网友 时间:2023-10-22 23:52

应该是妹妹没有录入数据库,联系防疫站,把妹妹的信息录进去。

热心网友 时间:2023-10-22 23:51

可能是学校做记录的时候给落下了,可以去学校查查看看,如果接种了,学校是有记录的,能不能让学校给补录一下。

热心网友 时间:2023-10-22 23:51

是不是刚打完的事儿啊,过两天了可能就能查到了,查不到的话去学校核实一下,应该有记录的

热心网友 时间:2023-10-22 23:52

应该是妹妹没有录入数据库,联系防疫站,把妹妹的信息录进去。
声明声明:本网页内容为用户发布,旨在传播知识,不代表本网认同其观点,若有侵权等问题请及时与本网联系,我们将在第一时间删除处理。E-MAIL:11247931@qq.com
弱弱的问一句R9 270X显卡怎么样~ 能带得起我的AMD 240CPU么?_百度知 ... i54570cpu华硕z87a主板要配多少的内存条和显卡 i5 3570k配R9 270X显卡,用什么主板和电源? 很容易上火是什么原因 口干舌燥五心烦热失眠多梦夜不能寐请问是什么原因,吃什么能有效... 想问看大家对老妻少夫的问题有何看法? ...战记第十三章第6关打法 山海战记13-6攻略-手游攻略-游戏鸟手游网 ...战记第十七章第1关打法 山海战记17-1攻略-手游攻略-游戏鸟手游网 ...山海战记9-6图文攻略-手游攻略-游戏鸟手游网 ...战记第十二章第2关打法 山海战记12-2攻略-手游攻略-游戏鸟手游网 我不喜欢我现在钻戒的款式,可以重新打造吗? 周继勇的外文论著目录 sci论文英文问题 澳大利亚悉尼大学病理学好不好 关于做酒的代理需要注意哪方面的细节问题? 做白酒代理要注意什么事项? 新手如何做酒水代理 现在的白酒代理怎么样啊,好不好做 做白酒代理怎么样 做白酒代理需要注意哪些问题? 代理酒,做酒水生意怎么样? 新手如何做酒水代理? 自己创业做白酒代理前景怎么样? 做酒水代理怎么样 qq等级半星号什么意思 oppo r17手机怎么不能设置照片规格了? oppor17如何把相片存入相册 快手极速版已经提现了,但是钱一直没有到上,这是怎么回事?需要怎么办? 唯品会上的每一样东西都是正品吗? 快手极速版已经提现了,但是钱一直没有到上,这是怎么回事?需要怎么办? 一条项链跟一个钻石戒指能不能去重新打个款式?想把它们溶了重新打个戒指, 买的成品钻石戒指能从新重做吗? 余兴龙的科研工作简介 国华商场买的钻石戒指款式旧了可以换新的吗 对人类有突出贡献的犹太人? 想问问钻石戒指可以改款式吗?我只知道可以改大小。如果可以修改款式,大概需要多少钱? 帮忙翻译一下医院用的部门名称 我有个钻戒,十年前结婚买的,但是现在感觉款式不好看了,想要换一个,可... 钻石戒指只能改动一次吗,为什么? 买的铂金钻石戒指,时间久了想改一下造型可以吗 魏海明的代表论文 周生生的钻石可以以旧换新,还是可以重新加工? 急求两篇英语作文。 钻石戒指可以二次加工吗 钻戒带着不合适,大了一圈,可以到专卖店再次调换一个合适的钻戒吗? pd950钻石戒指能否重打款示 几年前在钻石世家买了一枚克拉钻石戒指,现在可以换款吗? 在金伯利买的钻石戒指的发票丢了,能换其他款式吗 金至尊k金钻石戒指能不能换款 赛尔号的精灵有几个属性?